New Zealand vaccine producer closer to goal by integrating mRNA Covid-19 technology with Australian

Updated: Oct 19

AUCKLAND: COVID-19 Vaccination Corporation (CVC), New Zealand’s most experienced group of vaccine researchers have joined forces with Australia’s BASE Nucleic Acids Biomanufacturing Facility to produce an mRNA COVID-19 vaccine.

As mRNA vaccines have demonstrated their abilities to be quickly developed, CVC’s collaboration with BASE Nucleic Acids Biomanufacturing facility, part of the Protein Expression Facility at the University of Queensland, will explore how CVC’s T-cell vaccine technology can be rapidly adapted to this emerging technology.

BASE is c